Innovations in Cancer Fall 2021 | University Hospitals

UH Seidman Cancer Center Faculty Presentation Highlights from ASH 2021 and ASTRO 2021 Annual Meetings

Innovations in Cancer | Fall 2021

12/16/2021 By UH

Cleveland Team Develops New Method to Drive Robust Expansion and Activation of Natural Killer Cells

Approach promises to increase access to NK therapeutics - Innovations in Cancer | Fall 2021

12/14/2021 By UH

Anti-CD19 CAR T-Cells Produced Locally at UH Seidman Cancer Center Induce High Remission Rates in B-cell Malignancies, Study Finds

Clinical trials published in Nature Communications detail advantages of local approach - Innovations in Cancer | Fall 2021

12/14/2021 By UH

UH Seidman Cancer Center Using Machine Learning, Novel Statistical Methods to Identify Prostate Cancer Therapies

Urologic oncologist Jonathan Shoag, MD, finding new roles for old drugs - Innovations in Cancer | Fall 2021

12/6/2021 By UH

Trials Testing PEGylated Interleukins Against Advanced Melanoma Under Way at UH Seidman Cancer Center

Novel agents thought to preserve interleukin’s ability to boost T cell growth and fight cancer, without harmful side effects associated with high-dose interleukin - Innovations in Cancer | Fall 2021

12/6/2021 By UH

Prostate Cancer Screening Is a Top Priority at University Hospitals Urology Institute

Innovations in Urology | Fall 2021

11/17/2021 By UH

The Current and Future State of Prostate Cancer Care

UH experts share insights into latest developments and what new technologies are coming - Innovations in Urology | Fall 2021

11/16/2021 By UH